Status:
COMPLETED
Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study
Lead Sponsor:
MedtronicNeuro
Collaborating Sponsors:
Medtronic France SAS
Conditions:
Urinary Incontinence
Over Active Bladder
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to document the safety, the effectiveness, the continued performance at mid and long term, the morbidity and the percent of surgical revisions of the Interstim® therapy fo...
Eligibility Criteria
Inclusion
- Patient is at least 18 years old;
- Patient signed the Patient Data Release Form;
- Patient suffering from retention or Over Active Bladder;
- Patient is eligible for Interstim® system therapy.
Exclusion
- Difficulty of collecting follow up patient data;
- Patient not affiliated to social security.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 22 2021
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT02186041
Start Date
August 1 2014
End Date
March 22 2021
Last Update
July 16 2021
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier du Pays d'Aix
Aix-en-Provence, France, 13616
2
CHIC Alencon Mamers
Alençon, France, 61000
3
CHU Angers
Angers, France, 49933
4
Hopital Prive Sevigné
Cesson Sevigné, France, 35576